Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 2022
CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that…
News
Mainz Biomed to Host Key Opinion Leader Event at DDW 2022
Digestive Disease Week is the largest international gathering of physicians, researchers and academics in the…
Impel Pharmaceuticals to Report First Quarter 2022 Financial Results on Monday, May 16, 2022
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
Kala Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call
ARLINGTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…
Ascendis Pharma A/S to Participate in the BofA Securities 2022 Healthcare Conference
COPENHAGEN, Denmark, May 09, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) announced today…
Humacyte to Provide Human Acellular Vessels™ (HAVs™) to Front-line Hospitals in Ukraine for Treatment of Vascular Trauma Injuries
— First shipment of HAVs to six Ukrainian hospitals made today — — Product candidate…
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Study of Bomedemstat in Combination with Atezolizumab in Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO),…
Immix Biopharma Announces Share Repurchase Program
Immix Biopharma Announces Share Repurchase Program Immix Biopharma, Inc. (NASDAQ:IMMX) LOS ANGELES, May 09, 2022…
Alimera Sciences Reports First Quarter 2022 Results
Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021 U.S. Net…
Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders
Company enters into collaborations with leading next generation sequencing (NGS) companies to facilitate trial enrollment…
Synthetic Biologics to Host Conference Call and Webcast to Discuss First Quarter 2022 Operational Highlights and Financial Results
ROCKVILLE, Md., May 09, 2022 (GLOBE NEWSWIRE) — Synthetic Biologics, Inc. (NYSE American: SYN), a…
Apexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ Platform
-Webinar to be held Monday, May 16th at 8:00 a.m. PT/ 11:00 a.m. ET- SAN…
Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy
Initial data from open label Phase 2a study expected in late 2022 IRVINE, Calif., May…
LianBio Completes Phase 1 Pharmacokinetic Study of Mavacamten in Healthy Chinese Volunteers
Mavacamten demonstrated a favorable safety, tolerability and pharmacokinetic profile in healthy Chinese volunteers Study was…
Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer
Dr. Sandborn brings a wealth of clinical experience and knowledge to Ventyx as we advance our…
Arch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC Spring
World-renowned Wound Care Leaders, Terry Treadwell, MD, FACS and Brock Liden, DPM, Shared Insights on…
Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates
DALLAS, May 09, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering…
Adaptimmune Reports First Quarter Financial Results and Business Update
– Pooled data from Cohort 1 of the SPEARHEAD-1 trial and the Phase 1 trial…
Genenta Appoints Industry Veteran Tim Obara as Head of Business Development
Extensive experience in business development with AstraZeneca and GSK MILAN, Italy and NEW YORK, May…
Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results
Upcoming PDUFA date of May 24, 2022 for VP-102 NDA for the treatment of molluscum…